The relationship between FGF-23 and ghrelin levels in CKD patients: preliminary data


OZTURK S., OZKAN O., EFE M., Yazici H., Gursu M. , Kaya A. H. , et al.

MINERVA UROLOGICA E NEFROLOGICA, cilt.68, ss.227-232, 2016 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 68 Konu: 2
  • Basım Tarihi: 2016
  • Dergi Adı: MINERVA UROLOGICA E NEFROLOGICA
  • Sayfa Sayısı: ss.227-232

Özet

BACKGROUND: Fibroblast growth factor (FGF)-23 is a recently discovered phosphaturic hormone that increases in chronic kidney disease (CKD). It has been accepted as a determinant of mortality and a therapeutic target in these patients. Ghrelin is a hormone that has roles in energy and nutrient metabolism. Ghrelin level was found to be increased in CKD patients. This is a controlled study in which the relationship between FGF-23 and ghrelin levels in CKD patients has been studied.